Talent India Pharmaceuticals

What Talent India Pharmaceuticals does

Talent India Pharma is an Ahmedabad, Gujarat-based privately-held pharmaceutical formulation development and marketing company founded in 1985 (per the company's own legal records and website copyright notice, though some sources indicate 1991). The firm develops, manufactures, and markets over 220 generic pharmaceutical formulations across four core therapy areas: psychiatry (e.g., Escitalopram, Olanzapine, Quetiapine, Risperidone, Aripiprazole), neurology (e.g., Pregabalin, Gabapentin, Brivaracetam, Divalproex), dermatology and cosmetology (e.g., Ketoconazole, Mometasone, Adapalene, sunscreens), and diabetology (e.g., Glimepiride, Metformin, Teneligliptin, Vildagliptin, Telmisartan). Manufacturing is conducted at facilities approved by the FDA and WHO-GMP, supporting both domestic credibility and export-readiness.

The company operates a sales-led go-to-market model with pan-India distribution reach. Its customer base consists of psychiatrists, neurologists, dermatologists, diabetologists, and ultimately patients seeking affordable treatment for chronic and acute conditions prevalent in India (mental health disorders affecting roughly 1 in 7 Indians, diabetes affecting 62+ million, and skin diseases with prevalence ranging 8-60%). Marketing channels include field sales, Continuous Medical Education (CME) programs (national symposiums, round tables, web-casts), long-standing partnerships with medical societies including the Indian Psychiatry Society, mega health check-up camps, and large-scale patient awareness campaigns.

Talent India is privately held with no public listing, no parent company, and no disclosed institutional investors. Revenue is not publicly disclosed. With approximately 67 employees, the company appears to focus internal resources on formulation development, marketing, and distribution while leveraging contract manufacturing relationships. The website copyright extends from 1985 through 2021, indicating over three decades of continuous operation in the Indian pharmaceutical market.

Name

Talent India Pharmaceuticals

Legal name

Talent India Pharma

Website

https://talentindia.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

51–100 employees

Short description

Talent India Pharma is a privately-held Ahmedabad-based pharmaceutical company developing and marketing over 220 generic formulations across psychiatry, neurology, dermatology, and diabetology, serving Indian prescribers and patients through a pan-India distribution network.

Ownership category

akta.pro rank

Product category

Generic Pharmaceutical Formulations

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Generic pharmaceutical formulations
• Psychiatry and neurology medicines
• Dermatology and cosmeceuticals
• Anti-diabetic medications
• WHO-GMP manufacturing

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical formulations sales: Talent India develops and markets pharmaceutical formulations across four therapy areas. The company manufactures and sells generic pharmaceutical products including formulations for psychiatry, neurology, dermatology/cosmetology, and diabetology. Revenue is generated through product sales to healthcare providers and patients across India.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Talent India Pharmaceuticals develops, manufactures, and markets generic pharmaceutical formulations across four core therapy areas: Psychiatry, Neurology, Dermatology and Cosmetology, and Diabetology. The company offers more than 220 formulations sold under branded names through a pan-India distribution and field-sales network targeting healthcare practitioners. Manufacturing is conducted in FDA-approved and WHO-GMP certified facilities, and the portfolio spans tablets, capsules, sustained-release and mouth-dissolving tablets, topical gels/creams/ointments, syrups, injections, and softgels.

Product overview

Talent India Pharmaceuticals is a pharmaceutical formulation development and marketing company headquartered in Ahmedabad, Gujarat, with a portfolio of over 220 formulations spanning key therapy areas. The company operates across four core therapeutic segments: Diabetology (products like GLIMITAL, TENEE, VILDEE, VOGLITAL for diabetes management and TELMITAL for hypertension), Neurology (products like BRIVEE, GABALENT, PREEGA for epilepsy and neuropathic pain), Psychiatry (products like ESCITALENT, OLAY, QUETALENT for mental health disorders), and Dermatology & Cosmetology (products like KONAZ, METASONE, CLIFACE for skin conditions and YUVINIE sunscreens, BIOTEE supplements). The company focuses on making quality pharmaceutical products affordable and accessible across India, with manufacturing facilities approved by FDA and WHO-GMP.

Differentiator

Problem solved

Functional benefit

Products and services

• Psychiatry Pharmaceutical Formulations

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Indian Psychiatry Society (IPS)coreStrategic or Co-development PartnerTalent India has worked closely with the Indian Psychiatry Society and its regional chapters over the years to spread awareness about the importance of mental wellbeing across India. The company is committed to working alongside IPS to reach out and help maximum patients in their journey to attain mental well-being.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Eris Lifesciences: India-focused specialty pharma with strong chronic-disease focus in diabetes/cardiology and a chronic-prescription-driven model — comparable specialty pharma positioning in India.
• Torrent Pharmaceuticals: Indian pharma with strong diabetology/cardiovascular presence, also active in CNS and dermatology — comparable therapeutic mix with similar pan-India field force orientation.
• Ajanta Pharma: Mid-sized Indian specialty pharma with overlapping therapy footprint across dermatology, cardiology, and CNS — closely comparable therapeutic mix and India+Africa distribution model.
• Alkem Laboratories: Mid-to-large Indian pharma with a broad anti-infective, GI, CNS, and chronic-disease portfolio, comparable India-domestic orientation and similar multi-therapy positioning.
• Intas Pharmaceuticals: Large Indian generic player with a particularly strong CNS/neurology and psychiatry franchise, comparable CNS therapy focus, and pan-India + global distribution footprint.
• Micro Labs: Privately-held Indian pharma with similarly broad therapy coverage including CNS, cardiology, dermatology, and diabetology, and a comparable India-domestic, multi-therapy generic strategy.

Broad incumbents

• Zydus Lifesciences (Cadila): Diversified Indian pharma group with strong presence in dermatology, CNS, and chronic-disease categories — comparable multi-therapy positioning but with substantially greater scale and a biosimilars pipeline.
• Cipla: Major Indian pharma with significant respiratory, CNS, and chronic-disease franchises, offering overlapping therapies but with global scale and much larger R&D/manufacturing footprint.
• Mankind Pharma: One of India's largest domestic pharma companies covering dermatology, CNS, cardiovascular, and antidiabetics — overlaps directly on therapy areas but at materially larger scale and broader portfolio.
• Abbott India: Multinational pharma subsidiary with a strong established franchise in CNS, gastroenterology, and metabolic diseases across India — competes with Talent India in the same chronic-disease categories from a much larger parent.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/talent-india-pharmaceuticals

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Talent India Pharmaceuticals